Table 4.

Results of the four FCoV-exposed cats repeatedly sampled

	T0	T28a	T53	T83	ANOVA	Tukey HSD Test
						*	**
Total proteins (g/dL)	8.18±0.43	7.45±0.44	6.53±0.32	7.45±0.54	**	T53 vs. T28,T83	T53 vs. T0
A/G ratio	1.07±0.19	1.03±0.26	0.86±0.23	0.77±0.07	n.s.
Albumins (g/dL)	4.65±1.06	3.73±0.45	2.96±0.36	3.23±0.07	*	T0 vs. T53
Globulins (g/dL)	4.46±1.34	3.72±0.54	3.56±0.55	4.22±0.49	n.s.
α1-Globulins (g/dL)	0.45±0.16	0.44±0.17	0.29±0.06	0.49±0.41	n.s.
α2-Globulins (g/dL)	0.42±0.18	0.45±0.05	0.51±0.20	0.64±0.16	n.s.
β-Globulins (g/dL)	1.02±0.61	0.64±0.08	0.71±0.26	0.67±0.23	n.s.
γ-Globulin (g/dL)	2.30±0.37	2.19±0.40	2.06±0.31	2.41±0.17	n.s.
Serum amyloid A (μg/mL)	4.97±0.74	31.8±0.97	15.5±0.87	6.83±0.46	n.s.
Haptoglobin (mg/mL)	0.95±0.74	1.20±0.97	1.29±0.87	1.27±0.46	n.s.
α1-Acid glycoprotein (mg/mL)	0.97±0.37	1.10±0.48	0.76±0.38	0.92±0.44	n.s.

*P<0.05; **P<0.01; T₀=first sample; T28, T53, T83=28,53 and 83 days after T₀, respectively; n.s., not significant.

^aAppearance of the symptoms in another cat of the group.